It was found that Gd-based MRI CAs conjugated with NSAIDs suppressed the increase in cyclooxygenase-2 (COX-2) levels, ameliorated glial activation, and neuron damage that is phenotypic for stroke by mitigating neuroinflammation, which prevented reperfusion injury. The gene discussed is PTGS2; the disease is Stroke.